(2S,4R)-1-((S)-2-(8-(3-(3-(3-(4-(1-Aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)propanamido)octanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA5219268

Chembl Id: CHEMBL5219268

PubChem CID: 155410734

Max Phase: Preclinical

Molecular Formula: C60H71N11O5S

Molecular Weight: 1058.37

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCNC(=O)CCc2cccc(-c3ccc4nc(-c5cccnc5N)n(-c5ccc(C6(N)CCC6)cc5)c4n3)c2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C60H71N11O5S/c1-38-52(77-37-66-38)41-20-17-40(18-21-41)35-65-57(75)49-34-45(72)36-70(49)58(76)53(59(2,3)4)69-51(74)16-8-6-5-7-9-31-63-50(73)28-19-39-13-10-14-42(33-39)47-26-27-48-56(67-47)71(55(68-48)46-15-11-32-64-54(46)61)44-24-22-43(23-25-44)60(62)29-12-30-60/h10-11,13-15,17-18,20-27,32-33,37,45,49,53,72H,5-9,12,16,19,28-31,34-36,62H2,1-4H3,(H2,61,64)(H,63,73)(H,65,75)(H,69,74)/t45-,49+,53-/m1/s1

Standard InChI Key:  ULRMGHXVPVNIJG-ILVTXYBSSA-N

Alternative Forms

  1. Parent:

    ALA5219268

    ---

Associated Targets(Human)

AKT1 Tchem VHL/AKT1 (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1S1 Tchem Proline-rich AKT1 substrate 1 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1058.37Molecular Weight (Monoisotopic): 1057.5360AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Yu X, Xu J, Cahuzac KM, Xie L, Shen Y, Chen X, Liu J, Parsons RE, Jin J..  (2022)  Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells.,  65  (20.0): [PMID:36197750] [10.1021/acs.jmedchem.2c01454]

Source